Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q2 EPS of ($0.27), $0.12 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.